⌘K

Login Start Free

Home/Filings/4/0001610717-25-000081

4//SEC Filing

Cislini Jeff 4

Accession 0001610717-25-000081

CIK 0001628171other

View on SEC.gov Company Profile

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 5:43 PM ET

Size

4.7 KB

Accession

0001610717-25-000081

Insider Transaction Report

Form 4

Period: 2025-03-17

Revolution Medicines, Inc.RVMD

General Counsel

Transactions

Sale
Common Stock
2025-03-17$39.04/sh−1,458$56,921→ 59,764 total

Footnotes (2)

[F1]Transaction made pursuant to a Rule 10b5-1 instruction letter adopted on May 31, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of restricted stock units ("RSUs") after July 15, 2023.
[F2]Includes 54,195 RSUs.

Documents

1 file

4
form4.xmlPrimary

Issuer

Revolution Medicines, Inc.

CIK 0001628171

Entity typeother

Related Parties

1

filerCIK 0001969082

Filing Metadata

Form type: 4
Filed: Mar 18, 8:00 PM ET
Accepted: Mar 19, 5:43 PM ET
Size: 4.7 KB

View on SEC.gov